Th2 cells and cytokine networks in allergic inflammation of the lung by Coyle, Anthony J. & Tsuyuki, Shogo
Invited Review
Mediators of Inflammation 4, 239-247 (1995)
cytokines released from Th2 and Th2-1tke
cells are likely to be central to the pathophysio-
10gy of asthma and allergy, contributing to
aberrant IgE production, eosinophilia and,
perhaps, mucosal susceptibility to viral infection.
IL-4 has emerged as a central target, not only for
B cell IgE production, but also in the commitment
of both CD4+ and CD8+ T cells to cells with Th2
effector function capable of secreting IL-5 result-
lng in eosinophilic inflammation. In view of the
central role of this cytokine and the evidence that
glucocorticoids are unable to modify many IL-4
dependent effects, Th2 inhibitors may prove to
be novel therapies for the treatment of bronchial
asthma.
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Introduction
Them is now increasing evidence to suggest
that pro-inflammatory cytokines derived from
various subsets of T cells play a maior role in the
induction of allergic inflammation of the lungs.
Additionally, cytokines derived from other cell
types such as mast cells and eosinophils may
also be of importance in the maintenance/persis-
tence of this disease. This review discusses the
interactive cytokine networks that exist in the
lungs, which are believed to play an important
role in the aetiology of bronchial asthma.
recently, attention has been focused on the role
of lymphocytes in the pathophysiology of this
disease. In severe acute asthma, an increase in
the number of T cells expressing the activation
markers HLA-DR, CD25 and VLA-1 has been
reported.
2 The realization that CD4 + T cells can
be committed to a distinct phenotype that can
induce B cells to switch to IgE production and
recruit eosinophils to the lungs, mediated via the
secretion of cytokines, has led to the hypothesis
that lymphocytes play a major role in orchestrat-
ing the inflammatory response in the lungs of
asthmatic individuals.
Pathology of asthma
Bronchial hyperresponsiveness (BHR) to both
specific and nonspecific stimuli is a characteristic
feature of bronchial asthma. While the mechan-
isms underlying this exaggerated responsiveness
are still unclear, there is a considerable body of
evidence to suggest that mucosal inflammation of
the airways is of central importance. Perhaps the
most common pathological finding is an
increased number of eosinophils and mast cells
in the lung mucosa. It is currently believed that
damage to the epithelium is mediated by the
secretion of eosinophil-derived highly toxic catio-
nic proteins such as major basic protein (MBP).
In addition, ultrastructural abnormalities in the
architecture of the lungs of asthmatic individuals
have been reported, characterized by sub-
epithelial deposition of collagen types III and V
and fibronectin, the amount of which is corre-
lated with the number of myofibroblasts. More
CD4+ T cell subsets--the Th2 hypothesis
Mature T cells in the periphery can be divided
into either CD4 + and CD8 + populations. This
subdivision is associated with fundamental differ-
ences in their function, in that CD4 + T cells are
activated by soluble foreign proteins such as
allergens, presented by MHC class II molecules
on the cell surface of antigen presenting cells (B
cells, macrophages and dendritic cells). In con-
trast, CD8 + T cells are, in general, activated by
intracellular pathogens such as viruses, are MHC
class I restricted and are cytotoxic. Murine
CD4 + T cells can be further subdivided into
two distinct subsets, termed T helper 1 (Thl)
and T helper 2 (Th2), on the basis of their
restricted cytokine profile and ability to mediate
different immune functions. Activated antigen-
naive resting CD4 + T cell cells secrete mainly IL-
2. However, these cells can be primed under the
influence of different cytokines (and perhaps dif-
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ferent co-stimulatory signals) to either a Thl or that B7-knockout mice had virtually no immune
Th2 subset. Thl cells produce TNF-]3 and IFN-7 defects led to the speculation that additional
and are involved in delayed hypersensitivity CD28 ligands existed.12This indeed proved to be
responses. Th2 cells produce IL-4, IL-5 and IL-10 the case and a second co-stimulatory molecule
and provide help to B cells and as such, are termed B7-2 (CD86) has more recently been
believed to play a central role in the aetiology of identified,a B7-2 is expressed at extremely low
allergic disease. levels on resting B cells, but is rapidly upregu-
lated after cross linking of the B cell antigen
receptor or following stimulation with LPS.
a4 On
Th 11 inhm human B cells, B7-2 expression peaks within
24 h of activation, whereas B7-1 expression peaks
While the concept of Th2 subtype of CD4 + T several days later,a5 In addition, a second CD4 +
cells was originally defined in murine cell clones, T cell co-receptor, homologous to CD28 has
there is now evidence to suggest that a similar been identified, termed CTLA-4 and demon-
cytokine profile exists in individuals with allergic strated to be a second ligand for B7-1 and B7-
disease. Studies of T cell clones obtained from 2.a6 The different functional importance of CD28
the blood of patients sensitive to house dust and CTLA-4 is still unclear. However, in contrast
mite allergen demonstrated that the majority of to CD28, CTLA-4 expression is increased only
these clones produced IL-4 and IL-5 and low after activation,aa and as such may function to
levels of IFN-7 and IL-2 after antigen stimulation.
4 downregulate the T cell response,
a7
Likewise, lymphocytes obtained by bronchoalveo- While the importance of these co-stimulatory
lar lavage after allergen provocation of allergic signals for the production of IL-2 is well estab-
individuals have increased expression of mRNA lished, the role of these co-stimulatory molecules
for IL-3, IL-4 and IL-5.
5 IL-5 mRNA has also been in the production of Th2 pattern of cytokines is
identified by in situ hybridization of tissues less clear. However, it has recently been reported
obtained by bronchial biopsies of asthmatic sub- that stimulation through CD28 induces a Th2
jects and localized to beneath the epithelial base- response in vitro independent of IL-4 produc-
ment membrane.6’7 However, it is important to tion.
18 CD28 mediated stimulation of cloned
realize that the Thl/Th2 concept is based on human Th2 clones has also been reported to
extremely polarized panels of cytokines which induce responsiveness to IL-4 via the autocrine
can be generated in vitro by murine CD4+ T production of IL-lz.9 In vivo, administration of
cells and it is likely that more subtle intermediate CTLA-4Ig can inhibit IL-4 gene expression and
phenotypes exist in human disease. IgE production following infection with Heligmo-
somoides polygyrus.
2 Further evidence that co-
stimulation modifies the outcome of an immune
Antigen specific activation of CD4+ T response is provided by the observation that
cells treatment with CTLA-4 Ig prevents IL-4 produc-
tion following immunization with goat-anti-IgD.
2
Activation of CD4 + T cells require interaction In contrast, mice transgenic for soluble murine
between CD3 associated TCR z/[ complex and CTLA-4IG exhibit normal T cell priming and
specific antigen presented as peptides by class II cytokine production after immunization with a T
bearing cells. However, for complete cellular acti- cell dependent antigen.
22 The reasons for these
vation, a second signal is also required. More- discrepancies are unclear, but may be related to
over, antigenic stimulation through the TCR in insufficient levels of CTLA-4Ig in vivo to block
the absence of co-stimulation leads to a state of interactions between APC and T cells.
unresponsiveness or clonal anergy. The most
extensively studied co-stimulatory molecule is
CD28, which is constituatively expressed on the Cytokines and allergic inflammation
surface of naive CD4 + T cells, the engagement
of which is required for IL-2 production and T Regulation of IgE production: The principal
cell proliferation.
8 The importance of this feature that distinguishes atopic from non-atopic
pathway is illustrated in mice lacking the gene for individuals is their ability to develop IgE anti-
CD28 which exhibit impaired lymphokine secre- bodies to foreign proteins. During a CD4-MHC
tion.9 The first ligand for CD28, initially termed class II dependent cognate interaction of T and B
B7 (now classified as CD80), was identified on cells, contact-mediated costimulatory signals pro-
the surface of the B cell and subsequently shown vided by CD4 + T cells such as CD40L and
to provide co-stimulatory signals to antigen acti- membrane TNF-0t, initiate B cell activation.
vated T cells,m’l However, the demonstration During this process, IL-4 has been demonstrated
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in murine23’24 and human25’26 systems to instruct recruitment and transgenic mice overexpressing
B cells to switch to IgE production. Investigation the IL-5 gene develop peripheral blood, bone
of T cell cytokine production indicates that marrow and tissue eosinophilia.4 Furthermore,
enhanced in vitro IL-4 production is correlated administration of anti-IL-5 has been demonstrated
with enhanced in vivo IgE production. Whereas to inhibit eosinophilia induced by. nematodes5
T cell membrane-dependent activation signals are or antigen in sensitized animals. The precise
regarded as general competence signals to initi- source of IL-5 required for the induction of eosi-
ate B cell activation and induce cytokine respon- nophil infiltration is at present unclear, although
siveness, cytokines such as IL-4 provide a it is likely that it is produced from CD4 + T cells.
progressive signal inducing proliferation and IL-5 (in addition to ILo3 and GM-CSF) is also
switching of B cells to IgE. Inhibition of IL-4 in required for the survival of eosinophils in
vivo, either by administration of anti-IL-4 anti- vitro.37’38 However, in contrast to the require-
bodies
24 or by deletion of the IL-4 gene,
iv has ment for CD4 + T cell derived IL-5 for the
revealed the essential requirement of IL-4 for the recruitment of eosinophils to the lung,39 the
switch to IgE production. However, a recent source of lL-5 required for the survival of eosino-
study has demonstrated that IL-4 independent IgE phils in the lungs is from a non-CD4 + T cell
production can occur, although at a greatly source, possibly involving autocrine production
4o reduced level in IL-4 gene targeted mice.
28 from the eosinophil itself. IL-5 however, may
However, to what degree such production might not be the only factor involved in recruiting eosi-
be mediated by already switched B cells remains nophils to the mucosa and/or promoting their
to be determined. The situation, however, is survival and activation, as the observation of a
more complex in humans as IL-13, the message complete inhibition of eosinophil infiltration into
of which has been found in murine and human the airways after antigen challenge in mice
CD4+ cell clones of Th0 and Th2 phenotype, as lacking the IL-5 gene (M. Kopf, personal commu-
well as CD8 T cell clones,29 can also induce nication) may also reflect the requirement for
immunoglobulin isotype switching to IgE pro- maturation of eosinophils in the bone marrow.
ductionff The precise importance of IL-4 vs. IL- In this regard, other cytokines including the che-
13 as the principal cytokine involved in B cell mokines RANTES and the recently identified
isotope switch in allergic disease is at present eotaxin, may also be important in recruiting eosi-
unclear. However, recent studies have demon- nophils to the lung.
strated that naive CD4+ T cells (CD45RO--) RANTES, along with IL-8, MCP-1, MCAF and
primed through the TCR develop into effector eotaxin belong to the superfamily of structurally
cells that secrete IL-5 and IFN-2 and help B cell related low molecular weight cytokines which
IgE production via IL-13 and not IL-4.31 In con- contain four cysteines at identical relative posi-
trast, activation of CD4+ memory cells tions with a conserved Cys-Cys-(C-C) motif.
(CD45RO + ) also produce IL-4 and IL-5 and help RANTES was originally identified as an apparently
cell IgE through a combination of IL-13 and IL- T cell-specific inducible gene that was expressed
by cultured T cell lines.4- More recently, RANTES
IL-4 also plays a central role in the induction has been shown to be produced from activated
of the Th2 phenotype as shown by in vitro and platelets.
42 RANTES is eosinophil chemotactic for
in vivo experiments using IL-4 gene detected both eosinophils and for ’memory’ CD4+ T cells
mice. The importance of IL-4 in the cytokine net- in vitro and as such may contribute to the eosi-
works in the lung are discussed in more detail in nophil recruitment in allergic disease.4
the next section. Eotaxin, was originally identified as a factor
produced in the BAL of antigen-challenged
Development of eosinophilic inflammation: Over guinea-pigs, which, upon subsequent injection,
20 years ago, the development of eosinophilia in induced a selective accumulation of eosinophils
nematode infected rodents was demonstrated to in the skin
44 and lungs.45 Eotaxin has a 53%
be lymphocyte dependent.2 Subsequently, it was homology with MCP-1, 31% with MIP la and
shown that the soluble factor from T cells was 26% with RANTES. mRNA for eotaxin was shown
identical to B cell growth factor 2 (BCF II). This to be up-regulated 3 h after allergen provoca-
factor has been extensively studied and char- tion.
46 The role of eotaxin and other C-C che-
acterized and is now termed interleukin-5 (IL-5). mokines in the airways of asthmatic individuals
IL-5 has been shown to promote the growth and remains to be determined.
differentiation of eosinophils in culture and, in
contrast to IL-3 and GM-CSF, acts as a terminal CD8+ Th2 like cells---a mechanism for viral
eosinophil differentiation factor. In vivo, adminis- used exacerbations of asthma: CD8+ T cells
tration of exogenous IL-5 induces eosinophil typically produce a Thl like cytokine panel (IFN-
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,, IL-2) after in vitro stimulation. CD8+ T cells suggest that steroids may not be able to inhibit
mediate lysis of viral infected cells and inhibition some of the effects and the production of IL-4,
of viral replication through the production of and may therefore be intrinsically unable to sup-
IFN-. Moreover, it has been suggested that press the central underlying immunological pro-
CD8+ T cells down-regulate the CD4 + T cell cesses that drive eosinophilic inflammation in the
driven reslonse dependent on the production mucosa.
of IFN-’.
47;’48 However, recent observations from More recently, it has been shown that pred-
Erard and colleagues have shown that in the nisolone therapy fails to down-regulate mRNA for
presence of IL-4, activated CD8+ cells can IL-4 and IL-5 in steroid resistant asthmatics.55
switch their function to produce Th2 cyto- While the precise mechanisms by which steroid
kines.49 Additionally, these cells produce less resistance occurs is unclear, it has recently been
IFN-, and lose their cytotoxic potential. This demonstrated that IL-4 can down-regulate the
suggests that in allergic individuals, CD8+ T cell glucocorticoid receptor affinity in vitro.56 These
function may be re-directed if activated by a spe- observations suggest that inhibition of IL-4 may,
cific antigen in the presence of IL-4. In this in addition to providing an alternative therapy to
context, it has recently been demonstrated that steroids, prove to be a useful adjunct therapy in
MHC class I restricted viral antigen-specific acti- the treatment of asthma by possibly restoring
vation of CD8+ T cells in the presence of IL-4, normal steroid receptor function.
leads to a phenotype that produces IL-5 and
reduced amounts of IFN-t.
5 Moreover, in vivo,
the induction of an IL-4-dependent Th2 pheno- Cgtokin rgulion
type can switch viral-specific CD8+ T cells to Commitment
produce IL-5 and induce eosinophil recruitment
into the lungs.
5 These observations suggest that Activated antigen-naive resting CD4+ T cell
IL-4 is important not only in regulation of cells from non-allergic donors secrete mainly IL-
CD4 + T cell commitment, but has dramatic 2, with a very low production of IL-4 and IFN-,.
effects on CD8 + T cell function. Thus, this IL-4 These cells must be ’primed’ or ’committed’ to
mediated switch of CD8+ T cells to a Th2 like either a Thl (IFNq, producing) or Th2 (IL-4
phenotype, may not only exacerbate asthma producing) phenotype. It is now well established
severity by secreting IL-5, but the reduction in in vitro that IL-4 is essential for the commitment
IFN-, secretion may impair the normal host of naive CD4 + T cells to the Th2 phenotype
response, leading to delayed viral clearance from after either stimulation through the CD3
the lung. complex5v’58 or by a specific antigen.
59 Likewise,
studies performed in mice lacking the IL-4 gene
IL-4 and steroid resistant asthma: Glucocortico- have demonstrated the essential role of this
steroids are the single most effective class of cytokine in the development of Th2 immune
drug able to control symptoms and suppress response, as ex vivo stimulation of CD4+ T
overt airway inflammation in asthma, and are cells from these mice causes the secretion of
increasingly widely used as first line therapy. It greatly reduced amounts of IL-5 and IL-10, and
has recently been reported that treatment of fail to mount an IgE response. Likewise, these
allergic individuals with systemic prednisolone mice have a marked attenuation of IL-5 depen-
inhibits the expression of mRNA for IL-4 and IL-5 dent lung eosinophil recruitment following aem-
mRNA, whilst increasing mRNA for IFN-, sug- allergen provocation. The initial source of IL-4
gesting that one of the therapeutic effects of this required for Th2 commitment is at present
drug is to inhibit Th2 cell activation.5 Steroids uncertain. As discussed below, mast cells and
may also be effective by inducing apoptosis of basophils can produce IL-4 following cross-
eosinophils in the inflamed mucosa, by suppres- linking of IgE bound to the FceR1.6 However, it
sing IL-3, GM-CSF and IL-5 synthesis.52 is unlikely that mast cells would function as the
However, steroids are unable to suppress IL-4 primary source of IL-4 as in murine systems IgE
induced up-regulation of the endothelial adhe- production is strictly IL-4 dependent. Moreover,
sion ligand for eosinophils, and VCAM-153 and adoptive transfer of CD4 + T cells alone from
can enhance IL-4-driven IgE production in normal mice to IL-4 gene deleted mice results in
normal human lymphocytes. Furthermore, in a the development of an IgE response following
Th2-1ike T cell line, IL-4 selectively inhibits dexa- immunization, suggesting that for the induction
methasone-induced apoptosis. In this context, it of the B cell isotype switch to IgE, IL-4 is
has recently been demonstrated that in vitro derived solely from CD4+ T cells.
6 More
steroids are unable to inhibit IL-4 secretion from recently, a small subpopulation of T cells
murine Th2 cells.54 Together, these observations derived from the spleen and bearing the markers
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CD4+/NKI.1 + have been shown to rapidly between IL-4 and IFN-7 production will deter-
produce IL-4 mRNA upon activation, indepen- mine whether a Thl or a Th2 phenotype is pro-
dent of IL-4 itself.62 These observations suggest duced. This cross regulation has been elegantly
that possibly these cells can provide the first demonstrated in models of parasite infection
source of IL-4 at the outset of the immune where neutralizing antibodies against IL-4 or IFN-
response which subsequently primes naive 7 have been used to resolve or promote infec-
CD4+ T cells to the Th2 phenotype, tion by biasing the immune response in favour
IL-10 is a major cytokine produced by several of Thl or Th2 immunity.
different cell types. Mouse IL-10 is secreted from IL-12 is also believed to play a central role in
Th2, but not Thl cells.6 In addition, mouse the regulation of the immune response. IL-12,
CD5+ B cells produce IL-10 and it has been like TNF-cz, IL-1 and IL-6, is secreted principally
suggested that autocrine production of IL-10 by from macrophages in response to bacterial or
these cells acts as a growth factor.64 Murine mac- viral pathogens. IL-12 has been reported to facil-
rophages are also a source of IL-10. In contrast, itate the development of the Thl phenotype, effi-
the production of IL-10 by human cells is not ciently prime cells for IFN-7 production and
restricted to Th2 cells, and approximately one inhibit the commitment of IL-4 producing cells,v
third of CD8 + T cell clones, as well as Th0 and Similarly in vivo, IL-12 shifts the immune
Thl cells, produce IL-10 upon restimulation.65 In response from an IL-4 producing to an IFN-7
comparison to other cytokines, IL-10 is synthe- producing phenotype and provides protection
sized at a late stage after activation, with maximal against Leishmania major infection where Th2
expression of mRNA 24 h and protein production responses are lethal.71 More recently, it has been
48h later.65 IL-10 inhibits production of IFN-7 demonstrated that IL-12 will inhibit IL-4, IL-5, IL-6
and the proliferation of Thl, but not Th2 cells.63 and IL-13 mRNA and potentiate expression of
Moreover, inhibition was observed only in the mRNA for IFN-7, IL-2 and IL-10 after infection
presence of macrophages and not B cells, sug- with Schistosoma mansoni.72 Studies using neu-
gesting an indirect mode of action via the tralizing antibodies to IFN-7 demonstrated that
antigen-presenting cell itself.
66 This inhibition the effects of IL-12 on expression of IL-2, IL-4
appears to be unrelated to antigen processing, and IL-13 were mediated through IFN-7 produc-
as IL-10 also inhibited cytokine production from tion. However, the suppressive effects of IL-12 on
Thl cells induced by superantigens.65 IL-10 is a mRNA for IL-5 and IL-6 were relatively refractory
potent suppresser of macrophage activation and to IFN-T
72 raising the possibility that IL-12 may
inhibits the production of IL-lcz, IL-l]3, IL-6, IL-8, be a more important regulator of IL-5 production
TNF-z and GM-CSF from monocytes at both than IFN-7. In human T cells, IL-12 can switch
the protein and transcriptional level. IL-10, like the in vitro recall response of allergen-specific T
IL-4, up-regulates class II MHC expression on cells from atopic donors, from a Th2 to a Thl
small resting B cells and maintains their viability phenotype, suggesting that IL-12 can not only
in vitro, although in contrast to IL-4, IL-10 commit cells to a Thl phenotype, but also has
failed to increase expression of CD23. Thus, IL- the potential to reverse established immune
10 appears to down-regulate the immune response.
response by inhibiting the production of pro- IFN-cz has a wide range of immunomodulatory
inflammatory cytokines. In this context, it has activity and has been shown to suppress IgE pro-
74 -75 recently been demonstrated that IL-10 will duction both in vivo and in vitro. However, a
inhibit the accumulation of eosinophils in the direct effect on B cells is unlikely as IFN-cz fails
lung after antigen challenge, associated with a to inhibit B cell switch in vitro unless IFN-7 is
supression of TNF-cz in the bronchoalveolar present.7. The hypothesis that IFN-cz mediates its
lavage fluid.67 suppressive effect via IFN-7 production is sup-
IFN-7 has been shown to inhibit proliferation ported by the finding that IFN-cz induced
of Th2 cells and to inhibit IL-4 induced Th2 phe- inhibition of anti-IgD induced IgE and IgG1 pro-
notype commitment.8 Furthermore, IFN-7 has duction is associated with an increase in splenic
been shown to prime cells for further IFN-7 pro- mRNA for IFN-T.
77 This hypothesis has recently
duction. In vivo, IFN-7 has been shown to inhibit been supported using human CD4 + T cells,
the recruitment of eosinophils to the lungs of showing IFN-cz increases the frequency of IFN-7
sensitized mice.69 Moreover, anti-IFN-7 poten- producing CD4+ T cells and antagonizes the
tiated the antigen-induced eosinophil accumula- suppressive effects of IL-4 on IFN-7 production.
7
tion, suggesting that endogenous IFN-7 secreted As a consequence, both IL-12 IFN-7 and IFN-cz
following aerosol antigen provocation acts to may favour the induction and maintenance of
inhibit mucosal Th2 immune responses..9 It has Thl cells and counteract Th2 driven allergic reac-
therefore been proposed that the balance tions (Fig. 1).
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Cytokines from a non-CD4+ T cell source of human eosinophils with calcium ionophore
also leads to the production of IL-8.85 However,
Mast cells and basophils: Mast cell metaplasia in while IL-8 generation by monocytes or neu-
the bronchial mucosa is a pathological feature of trophils can be induced by IL-I[ and TNF-a,
chronic asthma. Mast cells have been shown to these cytokines failed to induce IL-8 secretion
be a rich source of cytokines and as such may from eosinophils. Eosinophils can also secrete
not only contribute to the acute responses TGF-8 and TGF-187 and as such may account
following antigen challenge, but may also play an for the eosinophil-derived stimulatory capacity
important role in the persistence of airway for fibroblast proliferation.
88 This is particularly
inflammation. Murine non-B/non-T cells (either important in bronchial asthma, where changes in
mast cells or basophils) have been reported to the architecture of the lung may contribute to
secrete IL-4 and IL-6,79 as well as TNF-a and the irreversibility of this disease. Likewise, human
GM-CSF upon cross linking of the Fce recep- eosinophils synthesize and secrete IL-69 which is
tor.79 Likewise, human mast cells also secrete able to facilitate IL-4 dependent IgE production,
IL4 upon IgE specific activation. More recently, and synergizes with IL-3 and GM-CSF for the
it has been shown that murine mast cells can maturation of multipotential granulocyte progeni-
also synthesize and secrete IL-13 upon IgE tors. Interestingly, IL-6 can also promote the
dependent activation and induce IgCe tran- secretion of IgA in mucosal tissue, which may
scripts.
8 Additionally, mast cells produce IL-3, subsequently ’arm’ eosinophils to secrete their
which together with IL-5, facilitate expansion of granular contents following activation.
the eosinophil lineage and enhance eosinophil
survival. IL-3 can also prime mast cells for cyto-
kine production (Table 1). Metachromatic cells Th2 inhibitors--novel asthmatic drugs?
may therefore have an important role as rapid
sources of cytokines triggered by IgE-dependent Important theoretical questions surround the
cell activation. Indeed, a positive feedback loop rational and therapeutic value of Th2 inhibitors
may operate involving IgE, mast cells and Th2 as they arise. A central question relates to the
cytokines derived from CD4 + T cells. Thus, role of IL-4 in the longevity and maintenance of
antigen exposure would lead to the production Th2 immune responses. While inhibition of IL-4
of IL-4 from CD4 + T cells which would then would prevent the switch B cells to IgE produc-
express CD40L upon activation and facilitate the tion, it would also inhibit the differentiation of
production of IgE, which in turn would ’arm’ naive T cells to the Th2 phenotype. However,
mast cells with the specific antibody. Activation therapeutically this would be an unachievable
of mast cells and basophils upon re-exposure goal. As allergic individuals retain their sensitivity
to the antigen would then lead to IL-4 produc- to allergens over many decades, it might be sup-
tion and amplification of the Th2 response posed that IgE-switched B cells and IL-4 com-
(Fig. 2). mitted Th2 cells retain their phenotypes for
prolonged periods. If this is the case, continuous
Eosinophils: While there is a considerable body exposure to environmental antigens would be
of evidence to suggest that eosinophils are final expected to reactivate these immune mechanisms
effector cells in the pathogenesis of allergic in an IL-4 independent manner. If allergic
disease and bronchial asthma, mediated largely
81 82 through the secretion of cationic proteins,
these cells also have the capacity to synthesize Table 1. Cytokine production from T cells, metachromatic cells
and eosinophils and release a wide array of cytokines. Addition-
ally, eosinophils express various surface markers Cytokine CD4 CD8 Meta- Eosino-
which suggest that they also may be immunologi- Thl Th2 CTTL "TH2 chromatic phils
cally competent cells. In this respect, it has
like" cells
recently been demonstrated that eosinophils IFN- +++ +++ +
express CD40L upon activation, suggesting that T +++ + nd ++ ++
these cells may be able to provide efficient help
k-2 +++ +++ +
IL-3 ++ ++ + nd ++ ++
to B cells to produce antibodies,s3 Human eosi- GM-CSF ++ ++ + nd ++ ++
nophils can store IL-5 in the granular matrix IL-4 +++ +++ +++ ++
which is secreted by either IgA, IgG or IgE
k-5 +++ +++ ++ ++
IL-10 +++ +++ 84 dependent mechanisms. Likewise, eosinophils IL-13 +++ + nd ++ nd
can also produce IL-3 and GM-CSF and as such,
The panel of cytokines produced by T cells, metachromatic cells and eosinophil activation may provide, in an auto- eosinophils (cytokine production: +++, high; ++ intermediate; + detect-
crine fashion, its own survival factors. Stimulation able;- not detectable; nd not determined).
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CD40
IL-4/IL-13
CD40L i osino hil
Ik-4
TCR
Th2
IL-5
APC
FIG. 1. Hypothetical positive feedback loop for the interaction between mast cells, lymphocytes and eosinophils. Antigen activated Th2
CD4+ T cells, provided with appropriate co-stimulatory signals, secrete IL-4 and express CD4OL, and as a consequence instruct B cells
to produce IgE. Likewise, Th2 cells produce IL-5 to recruit eosinophils into the lung. Interestingly, activated eosinophils may also
express CD40L to help B cell IgE production. IgE can then bind to the FCRI on mast cells, which, when activated, provide a further
source of IL-4 to maintain and amplify the immune response.
immune ’memory’ (persisting responsiveness to
recall antigens) is IL-4 independent, inhibitors of
Th2 cytokine production rather than commit-
ment will prove to be of greater therapeutic
value. However, in some murine systems of
ongoing IgE synthesis, there is evidence that IL-4
is required for the maintenance of the Th2 phe-
notype.9 However, the situation may be more
complex in humans, where IL-13 dependent
ongoing IgE synthesis may be more important.
However, inhibition of IL-4 may offer advantages
in steroid resistant asthma by preventing/rever-
sing impaired steroid receptor function55 and in
viral mediated exacerbations of asthma, where IL-
4 may be of central importance in switching
cytot0xic CD8+ T cells to a Th2 like pheno-
type.49’50 Likewise, selective inhibition of IL-5
offers the possibility of selectively suppressing
eosinophil infiltration into the airways. However,
whether other eosinophil factors such as eotaxin
can replace IL-5 in the lung of allergic individuals
remains to be determined. Finally, one important
point to determine is whether agents that sup-
press the production of Th2 cytokines from T
cells are also effective in suppressing the secre-
tion of cytokines from, for example, mast cells
and eosinophils, which may be important
sources of cytokines in established chronic
asthma.
IFNI
Stimulation
Inhibition
FIG. 2. Interactive cytokine network regulating the commitment
of CD4+ cells to a Th or Th2 phenotype.
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Conclusions
The cytokines released from Th2 and Th2-1ike
cells are likely to be central to the pathophysiol-
ogy of asthma and allergy contributing to aber-
rant IgE production, eosinophilia and, perhaps,
mucosal susceptibility to viral infection. IL-4 has
emerged as a central target, not only for B cell
IgE production, but also in the commitment of
both CD4+ and CD8 + T cells to cells with Th2
effector function capable of secreting IL-5 result-
ing in eosinophilic inflammation. In view of the
central role of this cytokine and the evidence that
glucocorticoids are unable to modify many IL-4
dependent effects, Th2 inhibitors may prove to
be novel therapies for the treatment of bronchial
asthma.
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